PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK

PT Industri Jamu dan Farmasi Sido Muncul Tbk

SIDO

ID1000130305

Pharmaceuticals

End-of-day quote INDONESIA S.E. Other stock markets 18:00:00 2024-07-15 EDT			5-day change	1st Jan Change
740 ^IDR	0.00%		-2.63%	+40.95%

04-25	PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-18	Nomura Adjusts Industri Jamu Dan Farmasi’s Price Target to IDR800 From IDR670, Keeps at Buy	MT

Hidayat family acquired 17.1% stake in PT Industri Jamu dan Farmasi Sido Muncul Tbk from Affinity Equity Partners Limited for approximately $200 million.

April 15, 2024

Hidayat family acquired 17.1% stake in PT Industri Jamu dan Farmasi Sido Muncul Tbk (IDX:SIDO) from Affinity Equity Partners Limited for approximately $200 million on April 5, 2024.
Hidayat family completed the acquisition of 17.1% stake in PT Industri Jamu dan Farmasi Sido Muncul Tbk (IDX:SIDO) from Affinity Equity Partners Limited on April 5, 2024.

Latest news about PT Industri Jamu dan Farmasi Sido Muncul Tbk

PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Nomura Adjusts Industri Jamu Dan Farmasi’s Price Target to IDR800 From IDR670, Keeps at Buy	04-18	MT
Hidayat family acquired 17.1% stake in PT Industri Jamu dan Farmasi Sido Muncul Tbk from Affinity Equity Partners Limited for approximately $200 million.	04-15	CI
Nomura Adjusts Industri Jamu Dan Farmasi Sido Muncul's Price Target to IDR670 From IDR750, Keeps at Buy	02-20	MT
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	02-19	CI
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Nomura Adjusts Industri Jamu Dan Farmasi Sido Muncul’s Price Target to 750 Rupiahs From 870 Rupiahs, Keeps at Buy	23-10-10	MT
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-26	CI
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-26	CI
Nomura Adjusts Industri Jamu dan Farmasi Sido Muncul's Price Target to IDR870 From IDR1,050, Keeps at Buy	23-07-13	MT
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Nomura Adjusts PT Industri Jamu Dan Farmasi Sido Muncul's Price Target to IDR1,050 From IDR920, Keeps at Buy	23-03-30	MT
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-10	CI
Nomura Adjusts Industri Jamu Dan Farmasi Sido Muncul's Price Target to IDR920 From IDR860, Keeps at Buy	23-01-30	MT
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Nomura Upgrades Industri Jamu dan Farmasi to Buy From Neutral, Keeps Price Target at 860 Rupiahs	22-10-18	MT
UBS Downgrades Industri Jamu Dan Farmasi Sido Muncul to Sell From Buy, Adjusts Price Target to 650 Rupiahs From 1,200 Rupiahs	22-08-26	MT
Nomura Downgrades Industri Jamu dan Farmasi to Neutral From Buy, Adjusts Price Target to 860 Indonesian Rupiahs From 1,170 Rupiahs	22-08-02	MT
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-28	CI
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-21	CI
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-06	CI
Nomura Adjusts Industri Jamu Dan Farmasi Sido Muncul’s Price Target to 1,170 Rupiahs From 1,000 Rupiahs, Keeps at Buy	22-01-07	MT
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-17	CI
Pt Industri Jamu Dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-26	CI

Chart PT Industri Jamu dan Farmasi Sido Muncul Tbk

Duration

Period

Chart PT Industri Jamu dan Farmasi Sido Muncul Tbk

More charts

Company Profile

PT Industri Jamu Dan Farmasi Sido Muncul Tbk is an Indonesia-based company, which carries out business activities in herbal industry, such as medical industry (pharmacy), herbs, cosmetics, foods and beverages related to health, commerce, land transportation, services, wastewater treatment, plantation and printing. The Company's segments include Herbal medicine and supplement, Food and beverages and Pharmacy. The Companyâs products include Tolak Angin Cair, Tolak Angin Anak + Madu, Tolak Angin Flu, Tolak Angin Sugar Free, Sido Muncul Tolak Linu, Kuku Bima Ener-G!, Susu Jahe, Kopi Jahe, Sido Muncul C-1000 (Dengan Ekstrak Lemon), Esemag, Sari Kunyit Soft Capsule, Tolak Angin Soft Capsule, Tolak Linu Soft Capsule, JSH Capsule, VCO Soft Capsule, Sido Muncul Vitamin D3 400 IU, Sido Muncul VItamin E 100 IU, Sido Muncul Vitamin E 300 IU, Minuman Madu dengan Jahe MADUSIDO, Tolak Angin Care, Tolak Linu Cool, Anak Sehat Rasa Anggur, Anak Sehat Rasa Coklat, and Anak Sehat Rasa Jambu Merah.

Sector

Pharmaceuticals

Calendar

2024-07-22 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for PT Industri Jamu dan Farmasi Sido Muncul Tbk

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

740 IDR

Average target price

743.4 IDR

Spread / Average Target

+0.45%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+40.95%	1.37B
DONG-E-E-JIAO CO.,LTD.	+9.94%	4.99B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-32.21%	3.61B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-1.43%	3.1B
TASLY PHARMACEUTICAL GROUP CO., LTD	-25.09%	2.64B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-11.46%	2.32B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+36.65%	1.85B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+37.15%	1.43B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-16.01%	1.39B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-26.42%	1.3B

Alternative Medicine

PT Industri Jamu dan Farmasi Sido Muncul Tbk

Equities

SIDO

ID1000130305

Pharmaceuticals

Hidayat family acquired 17.1% stake in PT Industri Jamu dan Farmasi Sido Muncul Tbk from Affinity Equity Partners Limited for approximately $200 million.

EPS Revisions